More recently, several publications demonstrated that the CRP/Alb ratio could be used to predict the prognosis of several cancers [11, 28, 29], and two additional studies confirmed the prognostic value of the CRP/Alb ratio in RCC patients [16, 30]. The gene discussed is CRP; the disease is cancer.